I

ICU Medical
D

ICUI

132.100
USD
-0.09
(-0.07%)
مغلق
حجم التداول
11,335
الربح لكل سهم
7
العائد الربحي
-
P/E
-34
حجم السوق
3,251,236,878
أصول ذات صلة
ABT
ABT
-0.770
(-0.56%)
135.620 USD
BAX
BAX
-0.760
(-2.42%)
30.610 USD
BDX
BDX
-2.215
(-1.27%)
172.245 USD
BMY
BMY
-0.910
(-1.80%)
49.760 USD
COO
COO
-1.198
(-1.69%)
69.665 USD
EW
EW
-0.720
(-0.95%)
75.170 USD
ISRG
ISRG
-0.86
(-0.17%)
511.99 USD
MDT
MDT
-1.240
(-1.40%)
87.270 USD
SYK
SYK
-3.14
(-0.83%)
377.30 USD
T
TFX
-2.070
(-1.70%)
119.950 USD
ZBH
ZBH
-1.940
(-2.08%)
91.260 USD
المزيد
الأخبار المقالات

العنوان: ICU Medical

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems(28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.